Xywav

Xywav · pharmadog

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 21, 2027

~1.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (155)

Mar 16, 2042method-of-use (U-3705)US 11779557
Mar 16, 2042method-of-use (U-3705)US 11779557
Mar 16, 2042method-of-use (U-3705)US 11779557
Mar 16, 2042method-of-use (U-3705)US 11779557
Feb 7, 2042method-of-use (U-3578)US 11583510
Feb 7, 2042method-of-use (U-3578)US 11583510
Feb 7, 2042method-of-use (U-3578)US 11583510
Feb 7, 2042method-of-use (U-3578)US 11583510
Feb 22, 2041method-of-use (U-4044)US 12138233
Feb 28, 2040formulationUS 10925844
Feb 28, 2040formulationUS 10925844
Feb 28, 2040formulationUS 10925844
Feb 28, 2040formulationUS 10925844
Sep 19, 2037method-of-use (U-3432)US 11426373
Jul 21, 2037formulationUS 10272062
Jul 21, 2037formulationUS 10272062
Jul 21, 2037formulationUS 10272062
Jul 21, 2037formulationUS 10272062
Jul 21, 2037formulationUS 10736866
Jul 21, 2037formulationUS 10736866
Jul 21, 2037formulationUS 10736866
Jul 21, 2037formulationUS 10736866
Jul 21, 2037method-of-use (U-3601)US 10952986
Jul 21, 2037method-of-use (U-3601)US 10952986
Jul 21, 2037method-of-use (U-3601)US 10952986
Jul 21, 2037method-of-use (U-3601)US 10952986
Jul 21, 2037formulationUS 10973795
Jul 21, 2037formulationUS 10973795
Jul 21, 2037formulationUS 10973795
Jul 21, 2037formulationUS 10973795
Jul 21, 2037formulationUS 11000498
Jul 21, 2037formulationUS 11000498
Jul 21, 2037formulationUS 11000498
Jul 21, 2037formulationUS 11000498
Jul 21, 2037formulationUS 11052061
Jul 21, 2037formulationUS 11052061
Jul 21, 2037formulationUS 11052061
Jul 21, 2037formulationUS 11052061
Jul 21, 2037formulationUS 11065224
Jul 21, 2037formulationUS 11065224
Jul 21, 2037formulationUS 11065224
Jul 21, 2037formulationUS 11065224
Jul 21, 2037method-of-use (U-3579)US 11400065
Jul 21, 2037method-of-use (U-3579)US 11400065
Jul 21, 2037method-of-use (U-3579)US 11400065
Jul 21, 2037method-of-use (U-3579)US 11400065
Jul 21, 2037formulationUS 11504347
Jul 21, 2037formulationUS 11504347
Jul 21, 2037formulationUS 11504347
Jul 21, 2037formulationUS 11504347
Jul 21, 2037method-of-use (U-3577)US 11602512
Jul 21, 2037method-of-use (U-3577)US 11602512
Jul 21, 2037method-of-use (U-3577)US 11602512
Jul 21, 2037method-of-use (U-3577)US 11602512
Jul 21, 2037method-of-use (U-3576)US 11602513
Jul 21, 2037method-of-use (U-3576)US 11602513
Jul 21, 2037method-of-use (U-3576)US 11602513
Jul 21, 2037method-of-use (U-3576)US 11602513
Jul 21, 2037formulationUS 11766418
Jul 21, 2037formulationUS 11766418
Jul 21, 2037formulationUS 11766418
Jul 21, 2037formulationUS 11766418
Jul 21, 2037method-of-use (U-3751)US 11826335
Jul 21, 2037formulationUS 11839597
Jul 21, 2037formulationUS 11839597
Jul 21, 2037formulationUS 11839597
Jul 21, 2037formulationUS 11839597
Jul 21, 2037formulationUS 11896572
Jul 21, 2037formulationUS 11896572
Jul 21, 2037formulationUS 11896572
Jul 21, 2037formulationUS 11896572
Jul 21, 2037method-of-use (U-3934)US 11986451
Jul 21, 2037method-of-use (U-3934)US 11986451
Jul 21, 2037method-of-use (U-3934)US 11986451
Jul 21, 2037method-of-use (U-3934)US 11986451
Jul 21, 2037formulationUS 12097175
Jul 21, 2037formulationUS 12097175
Jul 21, 2037formulationUS 12097175
Jul 21, 2037formulationUS 12097175
Jul 21, 2037method-of-use (U-4006)US 12097176
Jul 21, 2037method-of-use (U-4006)US 12097176
Jul 21, 2037method-of-use (U-4006)US 12097176
Jul 21, 2037method-of-use (U-4006)US 12097176
Jul 21, 2037formulationUS 12109186
Jul 21, 2037formulationUS 12109186
Jul 21, 2037formulationUS 12109186
Jul 21, 2037formulationUS 12109186
Jul 21, 2037formulationUS 12115142
Jul 21, 2037formulationUS 12115142
Jul 21, 2037formulationUS 12115142
Jul 21, 2037formulationUS 12115142
Jul 21, 2037formulationUS 12115143
Jul 21, 2037formulationUS 12115143
Jul 21, 2037formulationUS 12115143
Jul 21, 2037formulationUS 12115143
Jul 21, 2037formulationUS 12115144
Jul 21, 2037formulationUS 12115144
Jul 21, 2037formulationUS 12115144
Jul 21, 2037formulationUS 12115144
Jul 21, 2037formulationUS 12115145
Jul 21, 2037formulationUS 12115145
Jul 21, 2037formulationUS 12115145
Jul 21, 2037formulationUS 12115145
Jul 21, 2037method-of-use (U-4022)US 12128021
Jul 21, 2037method-of-use (U-4022)US 12128021
Jul 21, 2037method-of-use (U-4022)US 12128021
Jul 21, 2037method-of-use (U-4022)US 12128021
Jul 21, 2037formulationUS 12138239
Jul 21, 2037formulationUS 12138239
Jul 21, 2037formulationUS 12138239
Jul 21, 2037formulationUS 12138239
Jul 21, 2037formulationUS 12144793
Jul 21, 2037formulationUS 12144793
Jul 21, 2037formulationUS 12144793
Jul 21, 2037formulationUS 12144793
Jul 21, 2037formulationUS 12226377
Jul 21, 2037formulationUS 12226377
Jul 21, 2037formulationUS 12226377
Jul 21, 2037formulationUS 12226377
Jul 21, 2037method-of-use (U-4189)US 12303478
Jul 21, 2037method-of-use (U-4189)US 12303478
Jul 21, 2037method-of-use (U-4189)US 12303478
Jul 21, 2037method-of-use (U-4189)US 12303478
Sep 15, 2033patentUS 10213400*PED
Sep 15, 2033patentUS 10213400*PED
Sep 15, 2033patentUS 10864181*PED
Sep 15, 2033patentUS 10864181*PED
Sep 15, 2033patentUS 11253494*PED
Sep 15, 2033patentUS 11253494*PED
Sep 15, 2033patentUS 8772306*PED
Sep 15, 2033patentUS 8772306*PED
Sep 15, 2033patentUS 9050302*PED
Sep 15, 2033patentUS 9050302*PED
Sep 15, 2033patentUS 9486426*PED
Sep 15, 2033patentUS 9486426*PED
Mar 15, 2033method-of-use (U-2499)US 10213400
Mar 15, 2033method-of-use (U-2499)US 10213400
Mar 15, 2033method-of-use (U-1532)US 10864181
Mar 15, 2033method-of-use (U-3017)US 10864181
Mar 15, 2033method-of-use (U-3324)US 11253494
Mar 15, 2033method-of-use (U-3324)US 11253494
Mar 15, 2033method-of-use (U-3324)US 11986446
Mar 15, 2033method-of-use (U-3324)US 11986446
Mar 15, 2033method-of-use (U-1532)US 8772306
Mar 15, 2033method-of-use (U-1532)US 8772306
Mar 15, 2033method-of-use (U-1532)US 9050302
Mar 15, 2033method-of-use (U-1532)US 9050302
Mar 15, 2033method-of-use (U-1532)US 9486426
Mar 15, 2033method-of-use (U-1532)US 9486426
Jan 11, 2033formulationUS 10195168
Jan 11, 2033method-of-use (U-2938)US 10675258
Jan 11, 2033formulationUS 11554102
Jan 11, 2033formulationUS 8591922
Jan 11, 2033formulationUS 8901173
Jan 11, 2033formulationUS 9132107

FDA exclusivities (17)

Oct 16, 2031ODE-494Orphan Drug (7y)
Oct 16, 2031ODE-494Orphan Drug (7y)
Oct 16, 2031ODE-494Orphan Drug (7y)
Oct 16, 2031ODE-494Orphan Drug (7y)
May 1, 2030ODE-431Orphan Drug (7y)3.8y
May 1, 2030ODE-431Orphan Drug (7y)3.8y
May 1, 2030ODE-431Orphan Drug (7y)

(calcium oxybate + magnesium oxybate + potassium oxybate + sodium oxybate)

all catalysts(1)

News(0)

Report a data issue

comments(0)

🐶 often sniffed alongside

Patent cliff

patents (155)

FDA exclusivities (17)

Trials studying (calcium oxybate + magnesium oxybate + potassium oxybate + sodium oxybate)